Atlas Trials

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

Clinical trial NCT01054976 · COMPLETED

Trial details

NCT number
NCT01054976
Sponsor
Janssen Korea, Ltd., Korea
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2006-10-01
Primary completion
2009-02-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.